Apple supplier looks to raise up to $606M in HK listing, Bloomberg says
Lens Technology, a supplier to Apple (AAPL), is looking to raise as much as HK$4.8B, or $606M, in a Hong Kong listing, Julia Fioretti of Bloomberg reports.
Don't Miss TipRanks' Half Year Sale
Take advantage of TipRanks Premium for 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Tom's Guide
27 minutes ago
- Tom's Guide
Apple could launch a cheap Macbook next year — powered by the iPhone 16 Pro's chip
There are plenty of reasons to buy a MacBook, but saving money certainly isn't one of them. The best MacBooks give you a lot for your money, but they're not budget devices by any definition of the word. The good news is that analyst Ming-Chi Kuo claims Apple will be releasing a cheaper Macbook next year — and it'll apparently be powered by iPhone chips. According to Kuo, this machine will have a display somewhere around 13-inches, and will be powered by the A18 Pro chipset. That's the same chip as the iPhone 16 Pro, which has already proven to be a performance powerhouse. On top of that the machines could come in a variety of different colors, including silver, blue, pink and yellow. Apparently this new cheaper MacBook will go into mass production at the end of this year, or early next year. Apparently this new machine is projected to sell between 5 and 7 million units in 2026. According to Kuo, this will help Apple get shipment figures back to their pre-COVID shipment peak of 25 million units — up from 20 million in 2025. It's no secret that Apple's M Series chips came about because of the success of the iPhone's A-series. Compared to old Intel Macs, this offered far better performance and efficiency — boosting the capabilities and battery life. So bringing the A-series into the MacBook lineup brings that whole idea full circle. The main question I have is, how much of a hit would this rumored machine take in both those areas? The A-series may be able to perform well on iPhones, but there's a reason why the best iPads have been using M-series chips for the past few years. Get instant access to breaking news, the hottest reviews, great deals and helpful tips. I'm also curious as to how cheap this "cheap" Macbook might actually be. The M4 MacBook Air models start at $999, but is discounted to $849 right now. A cheaper model would have to be at least $200-$300 cheaper to make it worthwhile and that kind of price point could come with some other sacrifices like worse cameras, fewer ports and a less impressive screen. Of course we won't know for sure until Apple actually announces the laptop, which isn't likely to happen until it's ready to go on sale. Meaning we've got almost a year of waiting ahead of us.
Tom's Guide
30 minutes ago
- Tom's Guide
iPhone 17 Pro could get a huge unexpected design change — what we know
A major external change could be coming to the iPhone 17 Pro, claims leaker MajinBu, citing "direct sources among case manufacturers." That change will be the Apple logo moving lower down the phone, further away from the vertical center. It's a notable event since the last time this happened was with the iPhone X in 2017, which redesigned several elements of the iPhone and moved the logo a little off-center for a better sense of balance. Given the rumors the iPhone 17 Pro will feature a larger camera block, it seems likely this would be the cause of the moving logo. The new block seemingly spans the whole width of the phone, rather than just the corner where the camera lenses live. MajinBu only makes one mention of the iPhone 17 Pro Max, but between this and a later tweet we'll look at below, it seems that both the Pro and the Pro Max will get the new logo position. The article doesn't discuss the iPhone 17 or iPhone 17 Air either, although both of these have unique designs compared to the Pro models, so may not receive this alteration. MajinBu continues to explain how the logo's new home may have consequences for the iPhone 17 Pro's MagSafe magnet locations. As a result, casemakers, especially ones making transparent cases that highlight the logo specifically, are apparently keeping a close eye on what's happening, holding off on manufacturing to be on the safe side. We saw possible solutions in a later MajinBu X post, which showed how the ring of aligning magnets could lose a section around the logo. Get instant access to breaking news, the hottest reviews, great deals and helpful tips. The original article also suggests that manufacturers are looking into modular designs to ensure that, which ever way things are laid out, users can get the best possible experience. We can assume that Apple will keep quiet about its new iPhones for 2025 until the usual launch window in early September. But the rumors aren't going to stop in the meantime, so check our iPhone 17, iPhone 17 Air, iPhone 17 Pro and iPhone 17 Pro Max hubs for the latest info from the leak-o-sphere.
Yahoo
an hour ago
- Yahoo
2 Dividend Stocks to Buy on the Dip and Hold Forever
Apple and Amgen have faced company-specific issues over the past 12 months. However, both companies can navigate these challenges and perform well long after the dust settles. They also have strong dividend track records. 10 stocks we like better than Apple › Over the past year, Apple (NASDAQ: AAPL) and Amgen (NASDAQ: AMGN), two well-established companies that are part of the iconic Dow Jones Industrial Average, have faced significant headwinds. Apple is struggling due to the threat that President Donald Trump's trade agenda poses to its business, while Amgen faced a clinical setback late last year. Apple and Amgen have lagged the market over the trailing-12-month period, but despite their issues, both stocks are worth investing in for the long haul. Here's why. Apple does most of its manufacturing abroad, especially in China, the country that has been Trump's favorite target for tariffs. If heavy duties on imports from China stay in place, the iPhone maker will see its costs rise significantly; margins will drop, and so will earnings. These are legitimate concerns. But several aspects of Apple's business can help it overcome this potential headwind, even beyond the fact that the steep tariffs Trump is looking to impose may not survive his administration. First, Apple generates significant free cash flow, amounting to $98.5 billion over the trailing-12-month period. This can enable the company to shift production to countries with less severe tariffs while strengthening its domestic manufacturing capabilities, a project it's already working on. Second, Apple's competitive edge comes partly from its brand name, one of the most valuable in the world. Brand power can work wonders, allowing a corporation to pass on higher manufacturing costs to consumers without losing significant market share. That's another way Apple could navigate this problem. Meanwhile, the company has some important growth avenues, none more so than its services segment. Apple has an installed base of more than 2 billion devices, and more than 1 billion paid subscriptions. The services unit generates significantly higher margins than the hardware segment. As it continues to grow its sales faster than the rest of the business, it will eventually lead to stronger profits and margins. And Apple has the cash to invest in other monetization schemes; expect the tech giant to do precisely that in the long run. Its ambitions in fintech -- through several initiatives, including Apple Pay -- should pay off down the road. Lastly, Apple is a terrific dividend stock, despite a relatively unimpressive current yield of 0.5%. The company has doubled its payouts in the past decade. While Apple shares are down 19% this year, the stock still has a lot to offer long-term, growth-oriented investors: a strong moat, lucrative growth avenues, and an internal culture of innovation. Apple has crushed the market over long periods for good reasons, and it isn't about to stop. Amgen is seeking its next blockbuster medicine, a goal that drugmakers continually strive for in order to fend off competition, including that from biosimilars. Yet one of the company's most promising candidates, weight management medicine MariTide, failed to produce the kinds of results the market wanted in a phase 2 clinical trial, and the stock fell. Even so, MariTide looks far more promising than that plunge suggests. The medicine led to an average weight loss of about 20% after 52 weeks, with no plateau observed. And importantly, MariTide is administered once a month, versus once a week for the current leaders. That could attract a good number of patients, even with lower efficacy. Convenience is a great selling point, and a monthly dosing schedule is far more convenient. Elsewhere, the company continues to generate robust financial results. Amgen grew its revenue by a strong 9% year over year to $8.1 billion in the first quarter, while adjusted earnings per share rose 24% to $4.90. Several medications should drive top-line growth for a while, including Tepezza, a medicine for thyroid eye disease, and Tezspire, an asthma treatment. Amgen also has a deep pipeline, with several dozen programs that should eventually lead to new approvals and label expansions. The biotech's innovative capabilities have enabled it to perform well over the past few decades. That should remain the case. Finally, Amgen has been an exemplary dividend stock since it initiated its first payout in 2011; it has increased its dividend by 750% since then. Its forward yield currently tops 3.4%, and is much higher than the S&P 500's 1.3%. Amgen may have lagged broader equities over the past 12 months, but the stock still has a solid underlying business. That could deliver strong returns and consistent dividend growth if you initiate a position today and hold on for the long term. Before you buy stock in Apple, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Apple wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $713,547!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $966,931!* Now, it's worth noting Stock Advisor's total average return is 1,062% — a market-crushing outperformance compared to 177% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 23, 2025 Prosper Junior Bakiny has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Amgen and Apple. The Motley Fool has a disclosure policy. 2 Dividend Stocks to Buy on the Dip and Hold Forever was originally published by The Motley Fool Sign in to access your portfolio
